These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27174865)

  • 21. Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancer.
    KleinJan GH; van den Berg NS; Brouwer OR; de Jong J; Acar C; Wit EM; Vegt E; van der Noort V; Valdés Olmos RA; van Leeuwen FW; van der Poel HG
    Eur Urol; 2014 Dec; 66(6):991-8. PubMed ID: 25092539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging-radioguided occult lesion localization (ROLL) in breast cancer using Tc-99m macro-aggregated albumin and distilled water control.
    Philadelpho Arantes Pereira F; Martins G; Gregorio Calas MJ; Fonseca Torres de Oliveira MV; Gasparetto EL; Barbosa da Fonseca LM
    BMC Med Imaging; 2013 Sep; 13():33. PubMed ID: 24044428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward (Hybrid) Navigation of a Fluorescence Camera in an Open Surgery Setting.
    KleinJan GH; van den Berg NS; van Oosterom MN; Wendler T; Miwa M; Bex A; Hendricksen K; Horenblas S; van Leeuwen FW
    J Nucl Med; 2016 Oct; 57(10):1650-1653. PubMed ID: 27230927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical application of ROLL technique in non-breast diseases. Complementary use after PET-CT study].
    Infante JR; Rayo JI; Serrano J; Domínguez ML; García L; Durán C; Moreno M
    Rev Esp Med Nucl Imagen Mol; 2015; 34(3):162-6. PubMed ID: 25304844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients.
    Buckle T; Brouwer OR; Valdés Olmos RA; van der Poel HG; van Leeuwen FW
    J Nucl Med; 2012 Jul; 53(7):1026-33. PubMed ID: 22645296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radio-Guided Occult Lesion Localization With 99m Tc for the Localization of Nonpalpable Melanoma and Soft Tissue Sarcoma Lesions: A Feasibility Study.
    Reijers SJM; Mook FJ; Groen HC; Schrage Y; Stokkel MPM; Donswijk ML; van Houdt WJ
    Clin Nucl Med; 2024 Jan; 49(1):23-26. PubMed ID: 37991434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.
    van der Noordaa ME; Pengel KE; Groen E; van Werkhoven E; Rutgers EJ; Loo CE; Vogel W; Vrancken Peeters MJ
    Eur J Surg Oncol; 2015 Apr; 41(4):553-8. PubMed ID: 25707349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioguided occult lesion localization of cervical recurrences from differentiated thyroid cancer: technical feasibility and clinical results.
    Borsò E; Grosso M; Boni G; Manca G; Bianchi P; Puccini M; Arganini M; Cabria M; Piccardo A; Arlandini A; Orlandini C; Mariani G
    Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):401-11. PubMed ID: 24322795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
    Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for non-palpable breast lesions: a randomized prospective evaluation.
    Medina-Franco H; Abarca-Pérez L; García-Alvarez MN; Ulloa-Gómez JL; Romero-Trejo C; Sepúlveda-Méndez J
    J Surg Oncol; 2008 Feb; 97(2):108-11. PubMed ID: 18181162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of Real-Time Near-Infrared Fluorescence Tracer Imaging in Sentinel Node Biopsy for Oral Cavity Cancer Patients.
    Christensen A; Juhl K; Charabi B; Mortensen J; Kiss K; Kjær A; von Buchwald C
    Ann Surg Oncol; 2016 Feb; 23(2):565-72. PubMed ID: 26467454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An innovative multimodality approach for sentinel node mapping and biopsy in head and neck malignancies.
    Borbón-Arce M; Brouwer OR; van den Berg NS; Mathéron H; Klop WM; Balm AJ; van Leeuwen FW; Valdés-Olmos RA
    Rev Esp Med Nucl Imagen Mol; 2014; 33(5):274-9. PubMed ID: 24842707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-Dimensional Tumor Margin Demarcation Using the Hybrid Tracer Indocyanine Green-
    Meershoek P; van den Berg NS; Brouwer OR; Teertstra HJ; Lange CAH; Valdés-Olmos RA; van der Hiel B; Balm AJM; Klop WMC; van Leeuwen FWB
    J Nucl Med; 2019 Jun; 60(6):764-769. PubMed ID: 30504140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioguided occult lesion localization (ROLL) and excision of breast lesions using technetium-99m-macroaggregate albumin and air injection control.
    Machado RH; Oliveira AC; Rocha AC; Landesmann MC; Martins FP; Lopes SA; Gutfilen B; da Fonseca LM
    J Exp Clin Cancer Res; 2007 Sep; 26(3):323-7. PubMed ID: 17987790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of occult recurrent metastatic melanoma.
    Povoski SP; Hall NC; Martin EW; Walker MJ
    World J Surg Oncol; 2008 Jan; 6():1. PubMed ID: 18186915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodal hybrid imaging agents for sentinel node mapping as a means to (re)connect nuclear medicine to advances made in robot-assisted surgery.
    KleinJan GH; van den Berg NS; de Jong J; Wit EM; Thygessen H; Vegt E; van der Poel HG; van Leeuwen FW
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1278-87. PubMed ID: 26768422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
    Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
    Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radio guided occult lesion localization (ROLL) for non-palpable invasive breast cancer.
    Van Esser S; Hobbelink M; Van der Ploeg IM; Mali WP; Van Diest PJ; Borel Rinkes IH; Van Hillegersberg R
    J Surg Oncol; 2008 Dec; 98(7):526-9. PubMed ID: 18767074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.